论文信息 - Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up - 字舞流文

Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up

F. Pane | M. Picardi | M. Mascolo | D. Russo | N. Pugliese | R. Della Pepa | C. Giordano | A. Leone | A. D’Ambrosio | F. Muriano | M. G. Rascato | Violetta Marafioti | G. Delle Cave | F. Muriano